Updates on the Evolving Role of Multidisciplinary Care Teams for the Management of Patients with Duchenne Muscular Dystrophy
Evolving Treatment and Multidisciplinary Care in Managing Duchenne Muscular Dystrophy
Post-Test/Evaluation

Exit Survey

Questions marked with a * are required

19%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

A 4-year-old White child is diagnosed with Duchenne muscular dystrophy and receives initial corticosteroids and referral to other caregivers (eg, pulmonary, cardiac, orthopedic, etc). One year later, at 5 years of age, the parents ask about gene therapy. Is this child a candidate for gene therapy at this time?

No, the patient is too young

No, the patient is too old

No, because the patient has already received corticosteroids

Yes, the current indication for gene therapy in DMD is 5-6 years of age

Which of the following is true regarding multidisciplinary care for patients with Duchenne muscular dystrophy?

The responsibility of leading the care team and coordinating treatment for DMD should rest almost exclusively on primary care clinicians

While PCPs should exercise shared decision making with patients, specialists should dictate to patients what treatments they should take

The care of patients with DMD could involve primary care, neurology, orthopedics, pulmonology, cardiology and several others

Generally, in a patient with DMD, clinicians beyond neurology and primary care are not necessary